Adam C. Alexander, PhD, is an Assistant Professor in the Department of Family and Preventive Medicine at the University of Oklahoma Health Sciences Center. He is also the Co-Leader of the HEROES Research Lab at the TSET Health Promotion Research Center.
His research program focuses on addressing cancer-related health disparities, particularly among Black and socioeconomically disadvantaged populations, through innovative strategies that combine mobile health technology with community-engaged research. Currently, Dr. Alexander is leading efforts to design and evaluate community-driven smartphone applications aimed at reducing smoking rates and increasing cancer screening uptake among Black adults.
Academic Section(s):
OUFMC Research Division
Education:
Degree-Granting Institutions:
- University of Memphis, Memphis, TN, PhD, 2018 Social and Behavioral Sciences
- University of Memphis, Memphis, TN, MS, 2016 General Psychology
- University of Memphis, Memphis, TN, BA, 2012 Psychology
Postgraduate Training
- Postdoctoral Fellowship, Oklahoma Tobacco Research Center, Oklahoma City, OK, 09/2018 − 07/2020
Clinical/Research Interests:
- Tobacco-related health disparities among African Americans
- The impact of trauma and stress on physical and mental health, and health behavior
- Moderation and mediation analyses
- Structural equation modeling
- Mixed-methods research
Funding:
Principal Investigator. “HealthyCells: A Culturally-Tailored Smoking Cessation Smartphone Intervention for African Americans with Adjunctive Treatment for Sedentary Behavior.” National Institute of Minority Health and Health Disparities. (1 K01 MD015295-01A1). Funding Amount: $670,210 (05/8/2021 – 1/31/2026).
Principal Investigator. “Project Trinity (Health, Hope, and Healing): The Oklahoman African American Health Cohort Study”. TSET Health Promotion Research Center. Funding Amount: $50,000 (11/20/2020 – 6/30/2021).
Co-Investigator. “Automated Mobile Contingency Management for Smoking Cessation among Socioeconomically Disadvantaged Adults.” National Cancer Institute. (R01CA237331). Funding Amount: $638,669 per year (04/01/2021 – 03/31/2026).
Co-Investigator. “A pilot randomized controlled trial to determine feasibility and potential efficacy of COLO-CARE.” Stephenson Cancer Center (P30CA225520). Funding Amount: $25,000 (05/01/2021 – 04/30/2022).